Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can one weekly workout beat fatty liver? new study tests the ideal exercise frequency

NCT ID NCT05741957

First seen May 02, 2026 · Last updated Jun 19, 2026 · Updated 7 times

Summary

This study looks at whether exercising once a week or three times a week is better at reducing liver fat in adults who are centrally obese and have non-alcoholic fatty liver disease (NAFLD). Three hundred Chinese adults aged 18-69 will be assigned to either a once-weekly or thrice-weekly supervised treadmill program for 4 months. The goal is to find the most practical exercise frequency that still meets health recommendations and helps improve liver health.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • LKS Faculty of Medicine

    Hong Kong, Hong Kong

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

supervised treadmill exercise program

What this could lead to

If it works, this could show that even once-a-week exercise can meaningfully reduce liver fat, offering a practical option for busy people with NAFLD.

What could go wrong

This is a behavioral study with no blinding, so results may be influenced by participants' expectations. The effect may be modest and not apply to all NAFLD patients.

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatotic liver disease Obesity obesity disorder Obesity, Abdominal Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.